Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalon...
Saved in:
Main Authors: | Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli, Marc Miravitlles |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
by: Alexa Núñez, et al.
Published: (2021) -
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
by: Sandeep Bansal, et al.
Published: (2021) -
Mepolizumab and COPD in Real Life
by: Fernando Revuelta-Salgado, et al.
Published: (2022) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
by: Jafar Aljazeeri, et al.
Published: (2021) -
Towards precision in defining COPD exacerbations
by: Christine R. Jenkins
Published: (2021)